学术探索
学术期刊
新闻热点
数据分析
智能评审

Interferon β treatment in relapsing-remitting multiple sclerosis.: A review

被引：16
作者：
Grigoriadis, N [1 ]
机构：
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Neurol B, GR-54636 Thessaloniki, Greece
来源：
CLINICAL NEUROLOGY AND NEUROSURGERY | 2002年 / 104卷 / 03期
关键词：
early treatment; MRI; interferon;
D O I：
10.1016/S0303-8467(02)00048-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：251 / 258
页数：8
相关论文
共 64 条
  • [1] Multiple sclerosis -: From probable to definite diagnosis -: A 7-year prospective study
    Achiron, A
    Barak, Y
    [J]. ARCHIVES OF NEUROLOGY, 2000, 57 (07) : 974 - 979
  • [2] Pharmacokinetics and pharmacodynamics of interferon beta-1a (IFN beta-1a) in healthy volunteers after intravenous, subcutaneous or intramuscular administration
    Alam, J
    McAllister, A
    Scaramucci, J
    Jones, W
    Rogge, M
    [J]. CLINICAL DRUG INVESTIGATION, 1997, 14 (01) : 35 - 43
  • [3] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
    Barkhof, F
    Filippi, M
    Miller, DH
    Scheltens, P
    Campi, A
    Polman, CH
    Comi, G
    Ader, HJ
    Losseff, N
    Valk, J
    [J]. BRAIN, 1997, 120 : 2059 - 2069
  • [4] Magnetic resonance imaging in multiple sclerosis
    Clanet, M
    Berry, I
    [J]. CURRENT OPINION IN NEUROLOGY, 1998, 11 (04) : 299 - 303
  • [5] The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis
    Cole, SR
    Beck, RW
    Moke, PS
    Kaufman, DI
    Tourtellotte, WW
    [J]. NEUROLOGY, 1998, 51 (03) : 885 - 887
  • [6] Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study
    De Stefano, N
    Matthews, PM
    Fu, LQ
    Narayanan, S
    Stanley, J
    Francis, GS
    Antel, JP
    Arnold, DL
    [J]. BRAIN, 1998, 121 : 1469 - 1477
  • [7] DUQUETTE P, 1995, NEUROLOGY, V45, P1277
  • [8] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DUQUETTE, P
    GIRARD, M
    DESPAULT, L
    DUBOIS, R
    KNOBLER, RL
    LUBLIN, FD
    KELLEY, L
    FRANCIS, GS
    LAPIERRE, Y
    ANTEL, J
    FREEDMAN, M
    HUM, S
    GREENSTEIN, JI
    MISHRA, B
    MULDOON, J
    WHITAKER, JN
    EVANS, BK
    LAYTON, B
    SIBLEY, WA
    LAGUNA, J
    KRIKAWA, J
    PATY, DW
    OGER, JJ
    KASTRUKOFF, LF
    MOORE, GRW
    HASHIMOTO, SA
    MORRISON, W
    NELSON, J
    GOODIN, DS
    MASSA, SM
    GUTTERIDGE, E
    ARNASON, BGW
    NORONHA, A
    REDER, AT
    MARTIA, R
    EBERS, GC
    RICE, GPA
    LESAUX, J
    JOHNSON, KP
    PANITCH, HS
    BEVER, CT
    CONWAY, K
    WALLENBERG, JC
    BEDELL, L
    VANDENNOORT, S
    WEINSHENKER, B
    WEISS, W
    REINGOLD, S
    PACHNER, A
    TAYLOR, W
    [J]. NEUROLOGY, 1993, 43 (04) : 655 - 661
  • [9] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
    Ebers, GC
    Rice, G
    Lesaux, J
    Paty, D
    Oger, J
    Li, DKB
    Beall, S
    Devonshire, V
    Hashimoto, S
    Hooge, J
    Kastrukoff, L
    Krieger, C
    Mezei, M
    Seland, P
    Vorobeychi, G
    Morrison, W
    Nelson, J
    Freedman, MS
    Chrisie, S
    Nelson, R
    Rabinovitch, H
    Freedman, C
    Hartung, HP
    Rieckmann, P
    Archelos, J
    Jung, S
    Weilbach, F
    Flachenecke, P
    Sauer, J
    Hommes, O
    Jongen, P
    Brouwer, S
    McLeod, J
    Pollard, J
    Ng, R
    Sandberg-Wollheim, M
    Källén, K
    Nilsson, P
    Ekberg, R
    Lundgren, A
    Jadbäck, G
    Wikström, J
    Multanen, J
    Valjakka, M
    Carton, H
    Lissoir, F
    Declerq, I
    Vieren, M
    Peeters, E
    Dubois, B
    [J]. LANCET, 1998, 352 (9139) : 1498 - 1504
  • [10] Esmonde TFG, 2001, NEW ENGL J MED, V344, P229
1234567